Product search
Sort by
Search results
CEPHEN APTT 5
Measurement of the plasma recalcification time, in presence of the standardized aPTT (activated partial thromboplastin time) reagent (cephalin and activator), on human citrated plasma, to explore the activity of the intrinsic pathway coagulation factors (II, V, VIII, IX, X, XI, XII) and “anticoagulant” activities.
CEPHEN APTT 2.5
Measurement of the plasma recalcification time, in presence of the standardized aPTT (activated partial thromboplastin time) reagent (cephalin and activator), on human citrated plasma, to explore the activity of the intrinsic pathway coagulation factors (II, V, VIII, IX, X, XI, XII) and “anticoagulant” activities.
CEPHEN APTT 1
Measurement of the plasma recalcification time, in presence of the standardized aPTT (activated partial thromboplastin time) reagent (cephalin and activator), on human citrated plasma, to explore the activity of the intrinsic pathway coagulation factors (II, V, VIII, IX, X, XI, XII) and “anticoagulant” activities.
C4b-BP, anti-human, mouse, IgG
C4b-BP, anti-human, mouse, IgG (monoclonal)
C1-Inhibitor, anti-human, goat, IgG, purified, Peroxidase conjugated
C1-Inhibitor, anti-human, goat, IgG, purified, peroxidase conjugated (polyclonal)
C1-Inhibitor, anti-human, goat, IgG, purified
C1-Inhibitor, anti-human, goat, IgG, purified (polyclonal)
C1-Inhibitor, anti-human, goat, IgG, affinity purified
C1-Inhibitor, anti-human, goat, IgG, affinity purified (polyclonal)
Bivalirudin (Angiox®) Plasma Control
Quality control of clotting assays proposed for measuring bivalirudin concentrations in plasma (especially ref. CK002K, CK002L and 220202).
Bivalirudin (Angiox®) Plasma Calibrator
Calibrating the assays of bivalirudin using anti-IIa methods, especially with HEMOCLOT Thrombin Inhibitors kit (ref. CK002K, CK002L) or BIOPHEN DTI (ref. 220202).
BIOPHEN α2-Antiplasmin (Plasmin Inhibitor) LRT
Assay proposed for the measurement of plasmin inhibitor (α2-antiplasmin) activity in research applications.